
Freda Lewis-Hall
Freda Lewis-Hall, MD, a pioneer in medicine and leadership, has been on the front lines of health care for more than 40 years as a clinician, researcher, and leader in the biopharmaceuticals and life sciences industries. A passionate advocate for health equity and improved outcomes for all patients, Lewis-Hall has served in multiple leadership positions in the pharmaceutical industry. Most recently, she spent more than 10 years at Pfizer, Inc. on the executive leadership team as executive vice president, chief medical officer, and later chief patient officer. Prior to joining Pfizer, Lewis-Hall held various leadership roles within the biopharmaceutical industry at Vertex Pharmaceuticals, Bristol-Myers Squibb, Pharmacia Corporation, and Eli Lilly and Company. Before entering the biopharmaceutical industry, she served as vice chairperson of the Department of Psychiatry at Howard University College of Medicine and as an advisor to the National Institute of Mental Health.
Trained as a psychiatrist, Lewis-Hall began her medical career in frontline patient care and became well known for her work on the impact of mental illness on families and communities and on issues of health-care disparities. She recently completed a decade of service on the inaugural Board of Governors for the Patient-Centered Outcomes Research Institute. Lewis-Hall has served on the Board of Fellows of the Harvard Medical School and on the Board of Advisors of the University of Texas at Austin Dell Medical School. She continues her commitment to health, science, and advocacy by serving on the boards of the Foundation for the National Institutes of Health, the Milken Institute’s FasterCures, the Prostate Cancer Foundation, the Davos Alzheimer’s Collaborative, the Focused Ultrasound Foundation, and Every Cure. Lewis-Hall currently serves as a board member and advisor to a number of health and life sciences companies.
Lewis-Hall is a graduate of Johns Hopkins University and Howard University College of Medicine. She is a distinguished fellow of the American Psychiatric Association and an honorary fellow of the Faculty of Pharmaceutical Medicine of the Royal College of Physicians of the United Kingdom.